Monthly Archives: February 2018

SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma

Masum Saini, Aakanksha Verma and Sam J. Mathew Rhabdomyosarcoma (RMS) is a predominantly pediatric soft-tissue cancer where the tumor cells exhibit characteristics of the developing skeletal muscle, and the two most common sub-types are embryonal and alveolar RMS. Elevated activation of the receptor tyrosine kinase (RTK) MET is frequent in RMS and is thought to […]

Read more